Table 1

Baseline characteristics of the individuals with new atrial fibrillation (AF) between 2012 and 2018, and characteristics of the cohort of AF patients alive on 31 December 2018

Incident patients 2012–2018
(n=168 233)
Prevalent patients at the end of 2018
(n=226 847)
Age mean (SD), median73.4 (12.6), 74.874.7 (12.1), 75.5
Age group
20–64 years37 169 (22.1)41 791 (18.5)
65–74 years47 972 (28.5)64 868 (28.6)
≥75 years83 092 (49.4)120 008 (52.9)
Female sex82 716 (49.2)103 138 (45.5)
Hypertension131 392 (78.1)193 438 (85.3)
Diabetes40 922 (24.3)66 289 (29.2)
Ischaemic stroke or TIA28 608 (17.0)48 495 (21.4)
Congestive heart failure29 822 (17.7)64 083 (28.2)
Coronary heart disease47 415 (28.2)82 911 (36.5)
Hypercholesterolaemia89 967 (53.5)146 228 (64.5)
CHA2DS2-VASc score3.59 (1.87)4.01 (1.98)
  • Data are presented as n (%) or mean (SD).

  • CHA2DS2-VASc, congestive heart failure, hypertension, age≥75 years, age 65–74 years, diabetes mellitus, stroke, sex category (female), vascular disease; TIA, transient ischaemic attack.